Inventor · disambiguated record
John Wetzel
Also filed as: WETZEL JOHN · WETZEL JOHN M
20 granted patents·18 pending applications·314 citations·filing 1992–2023
95Inventor score
Files withSYNAPTIC PHARMA CORP18LUNDBECK & CO AS H7MARZABADI MOHAMMAD R2BLACKBURN THOMAS P1CERUVIA LIFESCIENCES LLC1
Top patents by PatentIndex Score
38 records- 0195US6727264B1Substituted anilinic piperidines as MCH selective antagonistsSYNAPTIC PHARMA CORP·Filed 2002·Granted Apr 27, 2004·61 cites·20 claims
- 0294US6720324B2Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Apr 13, 2004·51 cites·18 claims
- 0390US5403847AUse of α1C specific compounds to treat benign prostatic hyperlasiaSYNAPTIC PHARMA CORP·Filed 1992·Granted Apr 4, 1995·70 cites·52 claims
- 0487US7166635B23-imino-2-indolones for the treatment of depression and/or anxietyLUNDBECK & CO AS H·Filed 2005·Granted Jan 23, 2007·8 cites·11 claims
- 0587US5767131ADihydropyridines and new uses thereofSYNAPTIC PHARMA CORP·Filed 1994·Granted Jun 16, 1998·38 cites·18 claims
- 0678US7067534B1Substituted anilinic piperidines as MCH selective antagonistsLUNDBECK & CO AS H·Filed 2003·Granted Jun 27, 2006·7 cites·12 claims
- 0777US7465750B2Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methodsLUNDBECK & CO AS H·Filed 2006·Granted Dec 16, 2008·4 cites·16 claims
- 0871US5578611AUse of α-1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1994·Granted Nov 26, 1996·21 cites·36 claims
- 0970US6211198B1Dihydropyridines and new uses thereofSYNAPTIC PHARMA CORP·Filed 1998·Granted Apr 3, 2001·12 cites·16 claims
- 1067US7335665B2Spirocyclic piperidines as MCH1 antagonists and uses thereofLUNDBECK & CO AS H·Filed 2003·Granted Feb 26, 2008·4 cites·41 claims
- 1160US6310076B1Dihydropyridines and new uses thereofSYNAPTIC PHARMA CORP·Filed 2000·Granted Oct 30, 2001·1 cites·21 claims
- 1260US5780485AUse of α1c specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1995·Granted Jul 14, 1998·13 cites·56 claims
- 1360US2009318504A1Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methodsBLACKBURN THOMAS P·Filed 2008·Application pending·0 cites
- 1459US7473698B2Secondary amino anilinic piperidines as MCH1 antagonists and uses thereofLUNBECK AS H·Filed 2003·Granted Jan 6, 2009·3 cites·21 claims
- 1559US6015819AUse of alpha-1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1993·Granted Jan 18, 2000·10 cites·58 claims
- 1659US2024287057A1Process for synthesizing 2-bromolysergic acid diethylamide via controlled hydrolysis of bromocriptineCERUVIA LIFESCIENCES LLC·Filed 2023·Application pending·0 cites
- 1758US2007054910A1Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methodsKONKEL MICHAEL·Filed 2006·Application pending·0 cites
- 1857US7199135B2Substituted alkyl amido piperidinesLUNDBECK & CO AS H·Filed 2004·Granted Apr 3, 2007·1 cites·36 claims
- 1956US2007043080A1Substituted anilinic piperidines as MCH selective antagonistsMARZABADI MOHAMMAD R·Filed 2005·Application pending·0 cites
- 2054US5990128Aα1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1995·Granted Nov 23, 1999·9 cites·20 claims
- 2152US2004106623A1Compounds specific for the human alpha1d adrenergic receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 2003·Application pending·0 cites
- 2251US2003022900A1Compositions comprising alpha-1C specific compoundsSYNAPTIC PHARMA CORP·Filed 2002·Application pending·0 cites
- 2350US2006217418A1Substituted alkyl amido piperidinesMARZABADI MOHAMMAD R·Filed 2004·Application pending·0 cites
- 2449US7105544B2Substituted alkyl amido piperidinesLUNDBECK & CO AS H·Filed 2003·Granted Sep 12, 2006·0 cites·27 claims
- 2549US2004110821A1GAL3 receptor antagonists for the treatment of affective disordersFiled 2003·Application pending·0 cites
- 2649US2004242609A1Selective melanin concentrating hormone-1 (MCH1) receptor antagonists and uses thereofSYNAPTIC PHARMA CORP·Filed 2004·Application pending·0 cites
- 2748US6608086B2Dihydropyridines and new uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Aug 19, 2003·0 cites·18 claims
- 2848US2003176314A1Compounds for the treatment of painFiled 2002·Application pending·0 cites
- 2948US2003139431A1Guanidines which are agonist/antagonist ligands for neuropeptide FF (NPFF) receptorsFiled 2002·Application pending·0 cites
- 3047US2004127502A1Use of GAL3 antagonist for treatment of depressionSYNAPTIC PHARMA CORP·Filed 2003·Application pending·0 cites
- 3144US2004082615A13-Imino-2-indolones for the treatement of depression and/or anxietyFiled 2003·Application pending·0 cites
- 3244US2005154020A14-Aryl piperidinesSYNAPTIC PHARMA CORP·Filed 2004·Application pending·0 cites
- 3343US2005154022A14-aryl piperidinesLUNDBECK & CO AS H·Filed 2005·Application pending·0 cites
- 3438US6706716B2Compounds specific for the human α1d adrenergic receptor and uses thereofSYNAPTIC PHARMA CORP·Filed 2001·Granted Mar 16, 2004·0 cites·38 claims
- 3537US2003144310A1Molecules specific for NPFF receptors and uses thereofFiled 2002·Application pending·0 cites
- 3636US6602888B2Use of α1C specific compounds to treat benign prostatic hyperplasiaSYNAPTIC PHARMA CORP·Filed 1999·Granted Aug 5, 2003·1 cites·31 claims
- 3735US2005192337A1Processes and polymorphs of diaryl-indolone galr3 antagonistsFiled 2003·Application pending·0 cites
- 3832US2003078271A1Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methodsFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Wetzel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →